NCT04104360View on ClinicalTrials.gov

Galacto-oligosaccharides and Intestinal Activity

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 17, 2019

Primary Completion Date

August 15, 2024

Study Completion Date

September 15, 2024

Conditions
Healthy Adults
Interventions
DIETARY_SUPPLEMENT

Galacto-oligosaccharides

During this period subjects will receive 7.2 grams of Vivinal GOS supplements three times daily for four weeks

DIETARY_SUPPLEMENT

Maltodextrin

During this period subjects will receive 7.2 grams of maltodextrin supplements three times daily for four weeks

Trial Locations (1)

6229 HX

Maastricht University Medical Center, Maastricht

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER

NCT04104360 - Galacto-oligosaccharides and Intestinal Activity | Biotech Hunter | Biotech Hunter